Skip to content

Laser Capture Microdissection

Enabling Biomarker Discovery, Target Identification and Safety Assessment Through LCM-Based Analysis of Limited RNA Quantities in Tissue Samples

Epistem specialises in utilizing Laser Capture Microdissection (LCM) to isolate specific cell populations from tissue sections, which enables subsequent gene expression or DNA genotyping analysis. Our expertise in assessing very limited quantities of RNA using LCM can be applied to biomarker discovery, target identification and safety assessment.


Leveraging the Power of LCM for Gene Expression and Fibrosis Research

Laser Capture Microdissection (LCM) is a powerful technology that enables the isolation of specific cell populations from tissue sections, making it a valuable tool for gene expression analysis and biomarker discovery.

Epistem has developed highly sensitive proprietary techniques for analysing formalin-fixed, paraffin-embedded (FFPE) and fresh frozen samples using LCM. Our team of experts offer gene expression analysis services for both sample types, guiding customers in planning LCM studies to ensure optimal gene expression profiling.

Epistem has extensive experience in fibrosis research across various tissues such as lung, liver, and kidney, leveraging our LCM capabilities to identify key pathways and regulators by comparing fibrotic foci with normal comparator regions. We have assessed multiple clinical cohorts to understand inter-foci and inter-patient variation, as well as the underlying biology of fibrosis.

Our high-throughput LCM capabilities generate rich and deep transcriptional datasets, facilitating the validation or invalidation of target pathways in drug development programs.

Download the latest brochure

From brochures to posters, find all the information you need in a downloadable & printable format.

Contact Information

For more information regarding our services, please do not hesitate to contact us.

Contact Us